Item Type | Name |
Academic Article
|
p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma.
|
Academic Article
|
Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck.
|
Academic Article
|
Adjuvant irradiation for cervical lymph node metastases from melanoma.
|
Academic Article
|
Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma.
|
Academic Article
|
Feasibility of preoperative lymphoscintigraphy for identification of sentinel lymph nodes in patients with conjunctival and periocular skin malignancies.
|
Academic Article
|
Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma.
|
Academic Article
|
Conjunctival melanoma with a positive sentinel lymph node.
|
Academic Article
|
Reconstruction following radical resection of recurrent metastatic axillary melanoma.
|
Academic Article
|
Combined-modality therapy for patients with regional nodal metastases from melanoma.
|
Academic Article
|
In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
|
Academic Article
|
Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease.
|
Academic Article
|
DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma.
|
Academic Article
|
Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease?
|
Concept
|
Melanoma
|
Concept
|
Melanoma, Experimental
|
Academic Article
|
Histologic features of conjunctival melanoma predictive of metastasis and death (an American Ophthalmological thesis).
|
Academic Article
|
Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease.
|
Academic Article
|
The role of adjuvant radiotherapy in the local management of desmoplastic melanoma.
|
Academic Article
|
Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors.
|
Academic Article
|
Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial.
|
Academic Article
|
Sentinel-lymph-node biopsy.
|
Academic Article
|
Interval sentinel lymph nodes in melanoma.
|
Academic Article
|
Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma.
|
Academic Article
|
Extensive pigmented villonodular synovitis with markedly pigmented lymphadenopathy and its implication for differential diagnosis with malignant melanoma.
|
Academic Article
|
New TNM melanoma staging system: linking biology and natural history to clinical outcomes.
|
Academic Article
|
Biochemotherapy in patients with metastatic anorectal mucosal melanoma.
|
Academic Article
|
Reconstruction of marginal ear defects with modified chondrocutaneous helical rim advancement flaps.
|
Academic Article
|
Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center.
|
Academic Article
|
A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
|
Academic Article
|
Metastatic melanoma to lymph nodes in patients with unknown primary sites.
|
Academic Article
|
New American Joint Commission on Cancer staging system for melanoma: prognostic impact and future directions.
|
Academic Article
|
Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
|
Academic Article
|
Ethnic differences among patients with cutaneous melanoma.
|
Academic Article
|
Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire.
|
Academic Article
|
A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.
|
Academic Article
|
Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis.
|
Academic Article
|
Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients.
|
Academic Article
|
Metastasectomy for stage IV melanoma: for whom and how much?
|
Academic Article
|
Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.
|
Academic Article
|
Evidence-based treatment of early-stage melanoma.
|
Academic Article
|
Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients.
|
Academic Article
|
Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies.
|
Academic Article
|
Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients.
|
Academic Article
|
The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases.
|
Academic Article
|
Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma.
|
Academic Article
|
Sentinel lymph node biopsy for head and neck melanomas.
|
Academic Article
|
The new melanoma staging system.
|
Academic Article
|
Lymphatic mapping in the molecular era.
|
Academic Article
|
Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
|
Academic Article
|
Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy.
|
Academic Article
|
Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients.
|
Academic Article
|
Early-stage melanoma: staging criteria and prognostic modeling.
|
Academic Article
|
Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma.
|
Academic Article
|
Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
|
Academic Article
|
Cost effectiveness of adjuvant interferon in node-positive melanoma.
|
Academic Article
|
Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
|
Academic Article
|
Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa.
|
Academic Article
|
Melanoma adrenal metastasis: natural history and surgical management.
|
Academic Article
|
Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT00506311).
|
Academic Article
|
Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma.
|
Academic Article
|
Lymph node ratio predicts disease-specific survival in melanoma patients.
|
Academic Article
|
Sentinel node biopsy and standard of care for melanoma.
|
Academic Article
|
A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
|
Academic Article
|
Do melanoma patients from Southern climates have a worse outcome than those from Northern climates?
|
Academic Article
|
Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial.
|
Academic Article
|
Isolated limb infusion with cytotoxic agents: a simplified approach for venous access.
|
Academic Article
|
Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients.
|
Academic Article
|
Sentinel node biopsy for melanoma: an update after two decades of experience.
|
Academic Article
|
Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma.
|
Academic Article
|
Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: a 20-year experience.
|
Academic Article
|
Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy.
|
Academic Article
|
Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weights.
|
Academic Article
|
Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
|
Academic Article
|
Melanoma.
|
Academic Article
|
PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging.
|
Academic Article
|
Melanoma, version 2.2013: featured updates to the NCCN guidelines.
|
Academic Article
|
Frequency of nonsentinel lymph node metastasis in melanoma.
|
Academic Article
|
Adjuvant irradiation for axillary metastases from malignant melanoma.
|
Academic Article
|
Sentinel-node technique will change the design of clinical trials in malignant melanoma.
|
Academic Article
|
Patterns of early recurrence after sentinel lymph node biopsy for melanoma.
|
Academic Article
|
Correlation between prognostic factors and increasing age in melanoma.
|
Academic Article
|
An evidence-based staging system for cutaneous melanoma.
|
Academic Article
|
Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark.
|
Academic Article
|
Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
|
Academic Article
|
Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma.
|
Academic Article
|
Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients.
|
Academic Article
|
Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma.
|
Academic Article
|
Gender-related differences in outcome for melanoma patients.
|
Academic Article
|
Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
|
Academic Article
|
Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
|
Academic Article
|
Is sentinel-node biopsy superior to nodal observation in melanoma?
|
Academic Article
|
Effect of multiple-nodal basin drainage on cutaneous melanoma.
|
Academic Article
|
Interferon-alpha in high-risk melanoma patients.
|
Academic Article
|
Factors associated with false-negative sentinel lymph node biopsy in melanoma patients.
|
Academic Article
|
Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis.
|
Academic Article
|
Conditional survival estimates improve over 5 years for melanoma survivors with node-positive disease.
|
Academic Article
|
Second primary melanomas: incidence and outcome.
|
Academic Article
|
Surveillance after surgical treatment of melanoma: futility of routine chest radiography.
|
Academic Article
|
Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis.
|
Academic Article
|
A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer.
|
Academic Article
|
Sentinel-lymph-node biopsy for cutaneous melanoma.
|
Academic Article
|
Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
|
Academic Article
|
A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: comparison with the American Joint Committee on Cancer model.
|
Academic Article
|
Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review.
|
Academic Article
|
Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
|
Academic Article
|
Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma.
|
Academic Article
|
Sentinel lymph node biopsy for melanoma: a critical update for dermatologists after two decades of experience.
|
Academic Article
|
Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma.
|
Academic Article
|
Age as a prognostic factor in patients with localized melanoma and regional metastases.
|
Academic Article
|
An opportunity to ensure high-quality melanoma care through the use of a preoperative treatment algorithm.
|
Academic Article
|
Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas.
|
Academic Article
|
Intralesional therapy with PV-10 (Rose Bengal) for in-transit melanoma.
|
Academic Article
|
Interferon alfa-2a for melanoma metastases.
|
Academic Article
|
The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes.
|
Academic Article
|
Is incisional biopsy of melanoma harmful?
|
Academic Article
|
Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
|
Academic Article
|
Acne vulgaris: false-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma.
|
Academic Article
|
Melanoma.
|
Academic Article
|
Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis.
|
Academic Article
|
How should we view the results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)?
|
Academic Article
|
Current status of hyperthermic limb perfusion for in-transit melanoma.
|
Academic Article
|
Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib.
|
Academic Article
|
Melanoma.
|
Academic Article
|
A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma.
|
Academic Article
|
Final version of 2009 AJCC melanoma staging and classification.
|
Academic Article
|
Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma.
|
Academic Article
|
The prognostic significance of nonsentinel lymph node metastasis in melanoma.
|
Academic Article
|
Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.
|
Academic Article
|
Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma.
|
Academic Article
|
Sentinel lymph node biopsy for melanoma: critical assessment at its twentieth anniversary.
|
Academic Article
|
Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database.
|
Academic Article
|
Health-related quality of life in patients with melanoma: overview of instruments and outcomes.
|
Academic Article
|
Melanoma, version 4.2014.
|
Academic Article
|
Recent advances in the treatment of patients with malignant melanoma.
|
Academic Article
|
Presence of the human leukocyte antigen class II gene DRB1*1101 predicts interferon gamma levels and disease recurrence in melanoma patients.
|
Academic Article
|
Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.
|
Academic Article
|
Complications associated with sentinel lymph node biopsy for melanoma.
|
Academic Article
|
Lessons learned from the Sunbelt Melanoma Trial.
|
Academic Article
|
Innovations and challenges in melanoma: summary statement from the first Cambridge conference.
|
Academic Article
|
Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
|
Academic Article
|
Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
|
Academic Article
|
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.
|
Academic Article
|
Prognostic information from sentinel lymph node biopsy in patients with thick melanoma.
|
Academic Article
|
Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patients.
|
Academic Article
|
Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine.
|
Academic Article
|
A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using normothermic isolated limb infusion.
|
Academic Article
|
The relationship between blood IL-12p40 level and melanoma progression.
|
Academic Article
|
Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma.
|
Academic Article
|
Clinical study of noninvasive in vivo melanoma and nonmelanoma skin cancers using multimodal spectral diagnosis.
|
Academic Article
|
C-reactive protein as a marker of melanoma progression.
|
Academic Article
|
Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes.
|
Academic Article
|
Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study.
|
Academic Article
|
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
|
Academic Article
|
Lymphatic Mapping and Sentinel Node Biopsy in Melanoma.
|
Academic Article
|
The long-term risk of upper-extremity lymphedema is two-fold higher in breast cancer patients than in melanoma patients.
|
Academic Article
|
Association of Vitamin D levels with outcome in patients with melanoma after adjustment for C-reactive protein
|
Academic Article
|
Sentinel lymph node biopsy for ocular adnexal melanoma
|
Academic Article
|
The long-term risk of upper-extremity lymphedema is two-fold higher in breast cancer patients than in melanoma patients
|
Academic Article
|
Lymphatic mapping for melanoma
|
Academic Article
|
Inguinal Lymphadenectomy for Malignant Melanoma
|
Academic Article
|
Melanoma and pregnancy
|
Academic Article
|
Melanoma, version 2.2016 clinical practice guidelines in oncology
|
Academic Article
|
Melanoma Expression Genes Identified through Genome-Wide Association Study of Breslow Tumor Thickness
|
Academic Article
|
Recent advances in the treatment of melanoma
|
Academic Article
|
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
|
Academic Article
|
Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema
|
Academic Article
|
Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma
|
Academic Article
|
Excision Margins of Melanoma Make a Difference
|
Academic Article
|
Excision margins for primary cutaneous melanoma - Invited critique
|
Academic Article
|
Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes
|
Academic Article
|
Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma
|
Academic Article
|
Melanoma Expression Genes Identified through Genome-Wide Association Study of?Breslow Tumor Thickness.
|
Academic Article
|
Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein.
|
Academic Article
|
Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes.
|
Academic Article
|
Excision Margins of Melanoma Make a Difference: New Data Support an Old Paradigm.
|
Academic Article
|
Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.
|
Academic Article
|
Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.
|
Academic Article
|
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial.
|
Academic Article
|
NCCN Guidelines Insights: Melanoma, Version 3.2016.
|
Academic Article
|
Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma.
|
Academic Article
|
Counterpoint: Surgical Management of Lymph Node Basin in Sentinel Lymph Node-Positive Melanoma.
|
Academic Article
|
Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases.
|
Academic Article
|
Sentinel lymph node biopsy for ocular adnexal melanoma.
|
Academic Article
|
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.
|
Academic Article
|
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials.
|
Academic Article
|
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
|
Academic Article
|
Management of Sentinel-Node Metastasis in Melanoma.
|
Academic Article
|
Circulating Tumor Cells in Stage IV Melanoma Patients.
|
Academic Article
|
Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome.
|
Academic Article
|
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
|
Academic Article
|
The Great Debate at "Melanoma Bridge", Napoli, December 2nd, 2017.
|
Academic Article
|
A model for predicting low probability of nonsentinel lymph node positivity in melanoma patients with a single positive sentinel lymph node.
|
Academic Article
|
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
|
Academic Article
|
Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
|
Academic Article
|
Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
|
Concept
|
Melanoma-Specific Antigens
|
Concept
|
gp100 Melanoma Antigen
|
Academic Article
|
Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression.
|
Academic Article
|
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.
|
Academic Article
|
Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features.
|
Academic Article
|
Metastatic melanoma to the testis.
|
Academic Article
|
Correlation of Tumor Burden in Sentinel Lymph Nodes with Tumor Burden in Nonsentinel Lymph Nodes and Survival in Cutaneous Melanoma.
|
Academic Article
|
Functional annotation of melanoma risk loci identifies novel susceptibility genes.
|
Academic Article
|
KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma.
|
Academic Article
|
Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma.
|
Academic Article
|
Circulating Tumor Cells and Early Relapse in Node-positive Melanoma.
|
Academic Article
|
And Now for Something Completely Different: Immunotherapy Beyond Checkpoints in Melanoma.
|
Academic Article
|
Prognostic significance of acral lentiginous histologic type in T1 melanoma.
|
Academic Article
|
NCCN Guidelines? Insights: Melanoma: Cutaneous, Version 2.2021.
|
Academic Article
|
Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era.
|
Academic Article
|
Sentinel lymph node biopsy and completion lymph node dissection in melanoma.
|
Academic Article
|
Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes.
|
Academic Article
|
Utilization and evolving prescribing practice of opioid and non-opioid analgesics in patients undergoing lymphadenectomy for cutaneous malignancy.
|
Academic Article
|
Evaluation of Plasma IL-6 in Patients with Melanoma as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker.
|
Academic Article
|
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
|
Academic Article
|
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
|
Academic Article
|
Outcomes After Sphincter-Sparing Local Therapy for Anorectal Melanoma: 1989 to 2020.
|
Academic Article
|
Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
|
Academic Article
|
Is neoadjuvant therapy ready for prime time in melanoma?
|
Academic Article
|
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
|
Academic Article
|
Neoadjuvant relatlimab and nivolumab in resectable melanoma.
|
Academic Article
|
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.
|
Academic Article
|
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
|
Academic Article
|
Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.
|
Academic Article
|
Melanoma metastatic to the adrenal gland: An update on the role of adrenalectomy in multidisciplinary management.
|
Academic Article
|
Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma.
|
Academic Article
|
Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with Resectable Metastatic Melanoma.
|
Academic Article
|
Correction: Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with Resectable Metastatic Melanoma.
|
Academic Article
|
Final 5-Year Follow-Up Results Evaluating Neoadjuvant Talimogene Laherparepvec Plus Surgery in Advanced Melanoma: A Randomized Clinical Trial.
|
Academic Article
|
Adjuvant therapy in high-risk, node-negative melanoma.
|
Academic Article
|
Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial.
|